Amphista to initiate its first clinical trial for AMX-883, a potent, orally bioavailable DCAF16-dependent degrader of BRD9, for acute myeloid leukaemia (AML) in H2 2026The Phase 1 monotherapy dose-esc ...
The Chosun Ilbo on MSN
Han River Belt backlash prompts government to ease real estate tax plans
As Seoul Mayor Oh Se-hoon secured victory in the June 3 local elections despite losing in 15 out of 25 districts, fueled by support from the Han River Belt, speculation arises that the government’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results